Adial Pharmaceuticals ADIL
NASDAQ ADIL
$4.06 +0.05 (+1.25%)
As of: Oct 1, 2026 · 12:15 PM EDT

Adial Pharmaceuticals (ADIL) Notes Payables (2017 - 2021)

Updated

Adial Pharmaceuticals (ADIL) recorded Notes Payables of $29,088 in Q1 2021.

Analysis

Adial Pharmaceuticals (ADIL) Notes Payables (2017 - 2021) Analysis & Trends

At the end of FY2017, Adial Pharmaceuticals reported Notes Payables of $234,313.

  • The Q1 2021 figure is the highest quarterly Notes Payables since Q2 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Adial Pharmaceuticals 18.53 Mn 18.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 29,088.00
Jun 30, 2018 234,341.00
Dec 31, 2017 234,313.00
API Access

Adial Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=ADIL&period=max&api_key=YOUR_API_KEY